X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (40033) 40033
Book Review (9011) 9011
Newsletter (3416) 3416
Newspaper Article (1883) 1883
Publication (1813) 1813
Book Chapter (202) 202
Magazine Article (184) 184
Conference Proceeding (157) 157
Book / eBook (72) 72
Trade Publication Article (63) 63
Transcript (16) 16
Web Resource (15) 15
Dissertation (12) 12
Paper (6) 6
Data Set (4) 4
Reference (3) 3
Government Document (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (30241) 30241
humans (30018) 30018
thromboembolism (23973) 23973
female (16693) 16693
male (14333) 14333
middle aged (11596) 11596
venous thromboembolism (11376) 11376
aged (10334) 10334
risk factors (10125) 10125
thrombosis (8769) 8769
adult (8606) 8606
anticoagulants - therapeutic use (7904) 7904
anticoagulants (7743) 7743
hematology (6922) 6922
peripheral vascular disease (5905) 5905
prevention (5504) 5504
abridged index medicus (5468) 5468
thromboembolism - prevention & control (5217) 5217
surgery (5091) 5091
research (4807) 4807
risk (4744) 4744
treatment outcome (4683) 4683
deep-vein thrombosis (4483) 4483
pulmonary embolism (4405) 4405
care and treatment (4315) 4315
cardiac & cardiovascular systems (4251) 4251
thromboembolism - etiology (4221) 4221
aged, 80 and over (4131) 4131
warfarin (4078) 4078
retrospective studies (3893) 3893
stroke (3864) 3864
drug therapy (3852) 3852
medicine, general & internal (3819) 3819
patients (3721) 3721
anticoagulants - administration & dosage (3709) 3709
anticoagulants - adverse effects (3388) 3388
cancer (3382) 3382
mortality (3380) 3380
therapy (3189) 3189
analysis (3121) 3121
thromboembolism - drug therapy (3020) 3020
pulmonary-embolism (3015) 3015
medical research (2969) 2969
health risk assessment (2936) 2936
atrial fibrillation (2907) 2907
molecular-weight heparin (2907) 2907
health aspects (2898) 2898
management (2766) 2766
venous thrombosis (2701) 2701
medicine & public health (2685) 2685
risk assessment (2600) 2600
incidence (2577) 2577
venous thromboembolism - prevention & control (2562) 2562
medicine, experimental (2555) 2555
prospective studies (2555) 2555
adolescent (2543) 2543
diagnosis (2480) 2480
anticoagulation (2461) 2461
time factors (2459) 2459
risk-factors (2363) 2363
pregnancy (2342) 2342
complications (2276) 2276
follow-up studies (2217) 2217
prophylaxis (2183) 2183
hemorrhage - chemically induced (2167) 2167
heparin (2154) 2154
administration, oral (2096) 2096
cardiovascular diseases (1955) 1955
oncology (1945) 1945
cardiology (1892) 1892
warfarin - therapeutic use (1862) 1862
recurrence (1855) 1855
animals (1854) 1854
venous thromboembolism - etiology (1849) 1849
heparin - therapeutic use (1846) 1846
disease (1841) 1841
venous thromboembolism - drug therapy (1840) 1840
prognosis (1799) 1799
fibrinolytic agents - therapeutic use (1795) 1795
pharmacology & pharmacy (1729) 1729
young adult (1728) 1728
clinical trials (1671) 1671
heparin, low-molecular-weight - therapeutic use (1658) 1658
reports (1639) 1639
atrial fibrillation - complications (1634) 1634
bleeding (1603) 1603
deep vein thrombosis (1579) 1579
embolisms (1571) 1571
aspirin (1561) 1561
internal medicine (1551) 1551
rivaroxaban (1543) 1543
venous thrombosis - prevention & control (1543) 1543
medicine (1542) 1542
studies (1524) 1524
atrial fibrillation - drug therapy (1518) 1518
complications and side effects (1508) 1508
hemorrhage (1507) 1507
thromboembolism - epidemiology (1493) 1493
venous thrombosis - etiology (1463) 1463
metaanalysis (1436) 1436
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41913) 41913
German (1344) 1344
French (834) 834
Spanish (328) 328
Russian (319) 319
Italian (230) 230
Japanese (184) 184
Polish (125) 125
Czech (68) 68
Hungarian (63) 63
Korean (58) 58
Portuguese (56) 56
Chinese (53) 53
Turkish (47) 47
Danish (45) 45
Dutch (41) 41
Swedish (34) 34
Norwegian (28) 28
Romanian (20) 20
Croatian (18) 18
Serbian (17) 17
Hebrew (13) 13
Finnish (12) 12
Bulgarian (8) 8
Slovak (8) 8
Ukrainian (7) 7
Slovenian (4) 4
Lithuanian (3) 3
Icelandic (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Estonian (1) 1
Georgian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2 Suppl, pp. e691S - e736S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e419S - e496S
Background: This article addresses the treatment of VTE disease. Methods: We generated strong (Grade 1) and weak (Grade 2) recommendations based on... 
RIGHT-VENTRICULAR DYSFUNCTION | RECURRENT VENOUS THROMBOEMBOLISM | TISSUE-PLASMINOGEN-ACTIVATOR | RESPIRATORY SYSTEM | ACUTE PULMONARY-EMBOLISM | MOLECULAR-WEIGHT HEPARIN | VENA-CAVA FILTER | ORAL ANTICOAGULANT-THERAPY | INTRAVENOUS UNFRACTIONATED HEPARIN | LONG-TERM TREATMENT | DEEP-VEIN-THROMBOSIS | CRITICAL CARE MEDICINE | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Venous Thrombosis - blood | Heparin, Low-Molecular-Weight - adverse effects | Hemorrhage - prevention & control | Long-Term Care | Heparin, Low-Molecular-Weight - therapeutic use | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Fibrinolytic Agents - therapeutic use | Venous Thrombosis - prevention & control | Polysaccharides - therapeutic use | Drug Administration Schedule | Venous Thrombosis - drug therapy | Administration, Oral | Risk Factors | Polysaccharides - adverse effects | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Pulmonary Embolism - blood | International Normalized Ratio | Diagnostic Imaging | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e576S - e600S
Background: Antithrombotic therapy in valvular disease is important to mitigate thromboembolism, but the hemorrhagic risk imposed must be considered. Methods:... 
RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Heart Valve Diseases - blood | Mitral Valve | Thrombosis - complications | Ductus Arteriosus, Patent - drug therapy | Humans | Postoperative Complications - blood | Postoperative Complications - prevention & control | Stroke - complications | Hemorrhage - prevention & control | Rheumatic Heart Disease - blood | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Ductus Arteriosus, Patent - blood | Thromboembolism - prevention & control | Aspirin - adverse effects | Heart Valve Diseases - complications | Fibrinolytic Agents - therapeutic use | Rheumatic Heart Disease - drug therapy | Rheumatic Heart Disease - complications | Aspirin - therapeutic use | Thromboembolism - drug therapy | Postoperative Complications - drug therapy | Thrombosis - blood | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Catheterization | Heart Atria | Heart Valve Prosthesis | Risk Factors | Ductus Arteriosus, Patent - complications | Combined Modality Therapy | Evidence-Based Medicine | Stroke - blood | Thromboembolism - blood | Heart Valve Diseases - drug therapy | Thrombosis - drug therapy | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 01/2016, Volume 37, Issue 1, pp. 67 - 67
Document Reviewers: Victor Aboyans (CPG Review Coordinator) (France), Antonio Vaz Carneiro (CPG Review Coordinator) (Portugal), Stephan Achenbach (Germany),... 
Heart failure | Connective tissue disease | Lung disease | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | Left heart disease | LONG-TERM SURVIVAL | Endothelin receptor antagonists | Congenital heart disease | PRESERVED EJECTION FRACTION | RANDOMIZED CONTROLLED-TRIAL | Chronic thromboembolic | CALCIUM-CHANNEL BLOCKERS | Pulmonary hypertension | Phosphodiesterase type 5 inhibitors | Guidelines | RIGHT-VENTRICULAR DYSFUNCTION | Respiratory failure | Prostacyclin analogues | ENDOTHELIN-RECEPTOR ANTAGONIST | Pulmonary arterial hypertension | PLACEBO-CONTROLLED TRIAL | EXTRACORPOREAL MEMBRANE-OXYGENATION | SEVERE PORTOPULMONARY HYPERTENSION | Risk Assessment - methods | Hypertension, Pulmonary - diagnosis | Hypertension, Portal - complications | Humans | Echocardiography - methods | Tomography, X-Ray Computed - methods | Genetic Counseling | Hypertension, Pulmonary - therapy | Hypertension, Portal - diagnosis | Drug Interactions | Cardiac Catheterization - methods | Electrocardiography | Magnetic Resonance Angiography - methods | Elective Surgical Procedures - methods | Child | Biomarkers - metabolism | Exercise Therapy - methods | Cross Infection - prevention & control | Risk Factors | Social Support | Connective Tissue Diseases - therapy | Antihypertensive Agents - therapeutic use | Hemangioma - diagnosis | Hemangioma - complications | Heart Defects, Congenital - complications | Hypertension, Portal - therapy | HIV Infections - complications | Heart Defects, Congenital - diagnosis | Travel Medicine - methods | Health Status | Hypertension, Pulmonary - etiology | Hemoptysis - etiology | Genetic Testing - methods | Thromboembolism - diagnosis | Hemangioma - therapy | Balloon Embolectomy - methods | Exercise Test - methods | HIV Infections - diagnosis | Multimodal Imaging - methods | Adult | Female | Terminal Care - methods | Pregnancy Complications, Cardiovascular - therapy | Ventricular Dysfunction, Right - therapy | Therapies, Investigational - methods | Respiratory Function Tests - methods | Connective Tissue Diseases - diagnosis | Treatment Outcome | Arrhythmias, Cardiac - etiology | Thromboembolism - therapy | Pregnancy | Algorithms | Thromboembolism - complications | HIV Infections - therapy | Ventricular Dysfunction, Right - complications | Combined Modality Therapy - methods | Heart Defects, Congenital - therapy | Lung Transplantation - methods | Referral and Consultation | Patient Compliance | Connective Tissue Diseases - complications | Index Medicus
Journal Article
Book
1988, ISBN 9780808918912, xii, 306
Book
1990, ISBN 0702014745, Volume 3/no. 3., x, p. 483-836.
Book
1959, Modern medical monographs, 20, 131
Book
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 06/2019, Volume 321, Issue 24, pp. 2414 - 2427
Journal Article
Circulation, ISSN 0009-7322, 07/2012, Volume 126, Issue 3, pp. 343 - 348
Background-Dabigatran reduces ischemic stroke in comparison with warfarin; however, given the lack of antidote, there is concern that it might increase... 
anticoagulants | perioperative | atrial fibrillation | stroke prevention | surgery | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | PHARMACODYNAMICS | IMPAIRMENT | PHARMACOKINETICS | ETEXILATE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Postoperative Complications - prevention & control | Warfarin - adverse effects | Male | Hemorrhage - prevention & control | Dabigatran | Thromboembolism - epidemiology | Cardiac Pacing, Artificial - adverse effects | Warfarin - administration & dosage | Incidence | Benzimidazoles - administration & dosage | Aged, 80 and over | Female | Thromboembolism - drug therapy | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Blood Loss, Surgical - prevention & control | Stroke - prevention & control | beta-Alanine - adverse effects | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Brain Ischemia - prevention & control | Postoperative Complications - epidemiology | Anticoagulants - adverse effects | Cataract Extraction - adverse effects | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Usage | Warfarin | Dabigatran etexilate | Drug therapy | Health aspects | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 24, pp. 2347 - 2349
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2008, Volume 51, Issue 8, pp. 818 - 825
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e195S - e226S
Background: This guideline addressed VTE prevention in hospitalized medical patients, outpatients with cancer, the chronically immobilized, long-distance... 
CATHETER-RELATED THROMBOSIS | GRADUATED COMPRESSION STOCKINGS | SURGICAL ADJUVANT BREAST | COA REDUCTASE INHIBITORS | VENOUS THROMBOEMBOLIC DISEASE | RESPIRATORY SYSTEM | LONG-HAUL FLIGHTS | MOLECULAR-WEIGHT HEPARIN | DEEP-VEIN THROMBOSIS | HOSPITALIZED MEDICAL PATIENTS | CRITICALLY-ILL PATIENTS | CRITICAL CARE MEDICINE | Humans | Heparin, Low-Molecular-Weight - adverse effects | Immobilization | Heparin - therapeutic use | Hemorrhage - prevention & control | Heparin - adverse effects | Heparin, Low-Molecular-Weight - therapeutic use | Heparin - pharmacokinetics | Venous Thromboembolism - drug therapy | Venous Thromboembolism - blood | Fibrinolytic Agents - adverse effects | Neoplasms - complications | Venous Thromboembolism - prevention & control | Neoplasms - blood | Societies, Medical | Fibrinolytic Agents - pharmacokinetics | Fibrinolytic Agents - therapeutic use | Stockings, Compression | Polysaccharides - therapeutic use | Intermittent Pneumatic Compression Devices | Risk Factors | Polysaccharides - adverse effects | Combined Modality Therapy | Hemorrhage - blood | Hospitalization | Evidence-Based Medicine | Ambulatory Care | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Venous Thromboembolism - etiology | Travel | Heparin, Low-Molecular-Weight - pharmacokinetics | Critical Care | Hemorrhage - chemically induced | Polysaccharides - pharmacokinetics | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Journal Article